Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by miningfundi


T.III

RE:RE:RE:conference call

Bravo & egss, I expect that material exploration will only begin after...

April 2, 2019

T.III

RE:conference call

Imperial also expects that, immediately after the deal closes, Newcrest will...

April 2, 2019

HSDT

RE:RE:Oppenheimer Mar 15

The final step is the De Novo request decision. Under <a href="https:...

March 19, 2019

T.III

RE:Good, Bad, and Ugly.

There is no additional debt. One noteholder refused to extend the repayment...

March 18, 2019

T.III

RE:RE:RE:Newcrest Webcast

Agreed - excellent presentation and webcast, especially the Q&A session...

March 15, 2019

HSDT

RE:Mgmt Compensation while still in development phase

Just for clarity, most of Deschamps' 2017 compensation comprised options...

March 12, 2019

HSDT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Oppenheimer: Initiating Coverage With Outperform Rating

With a "friend" like the Opco analyst, who needs enemies! So he...

March 11, 2019

HSDT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Oppenheimer: Initiating Coverage With Outperform Rating

What I am expecting from HSM is what I get from every start-up I have...

March 11, 2019

HSDT

RE:RE:RE:RE:RE:RE:RE:RE:Oppenheimer: Initiating Coverage With Outperform Rating

Anybody who has held a senior corporate position knows that corporations plan...

March 10, 2019

T.III

RE:Newcrest pays 800 million for 70%

Very quick analysis, SO CAUTION ADVISED:   Value of Red Chris: US...

March 10, 2019

HSDT

RE:RE:RE:RE:RE:Oppenheimer: Initiating Coverage With Outperform Rating

FDA approval is critical to the success of HSM. Any competent analyst would...

March 6, 2019

HSDT

RE:RE:Oppenheimer: Initiating Coverage With Outperform Rating

"Our estimates currently don't assume FDA approval in 2019." Is...

March 6, 2019

T.III

RE:going to be interesting week!

I agree, judging from the price jump today. But hopefully not tomorrow...

February 28, 2019

VMD

RE:RE:RE:500k shares traded today

Anonymous was the biggest NET seller - 93% of NET sales! The biggest NET...

February 28, 2019

T.III

RE:RE:Extension of credit facilities - deal soon?

The Senior Unsecured Notes ratings according to III's March 2018 AIF were...

February 19, 2019

T.III

Extension of credit facilities - deal soon?

Interesting news release on Friday regarding credit extensions. Judging from...

February 17, 2019

VMD

RE:Revenue Growth 38.9%

At the current share price, the EV/2018 EBITDA ratio is about 10.0. A more...

February 4, 2019

HSDT

RE:RE:Information for FDA - why the timing?

Thanks prokofiev, you make a good point: it seems that the FDA is requesting...

January 30, 2019

HSDT

Information for FDA - why the timing?

Management: “We believe we have the data and information to address FDA’s...

January 29, 2019

T.III

RE:Murray Edwards in for more

Larry Moeller, a director, also acquired shares (24,792) at the same price on...

January 23, 2019